All News

The CDC made this recommendation after reviewing relevant literature and noting that complete testing jumped from about only two-thirds of patients to nearly all patients.

In a study of adolescents and young adults with sickle cell disease (SCD), researchers did not find a link between neurocognitive performance and pain and fatigue.

Olalekan Ajayi, PharmD, MBA, 2023-2024 president of the Association of Community Cancer Centers, discusses what practices should do to succeed under the Enhancing Oncology Model (EOM).

Amazon’s online pharmacy aims to improve access and price transparency for insulin; cases of the COVID-19 Eris variant are increasing globally; the Department of Justice (DOJ) responds to pushbacks of Medicare's drug price negotiation program from the Chamber of Commerce (COC).

A recent study found that most infants who required intensive care for respiratory syncytial virus (RSV) were healthy and born at term, indicating that preventive interventions for RSV must target all infants, according to the authors.

Jeff Patton, MD, CEO of OneOncology, joins Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for episode 3 of "Oncology Onward: Conversations With Innovators and Changemakers in Cancer Care."

Theory-based smoking cessation interventions helped to motivate patients with chronic obstructive pulmonary disease (COPD) who smoke to quit, ultimately improving their quality of life and lung function.

The FDA has granted accelerated approval to elranatamab-bcmm (Elrexfio) for the treatment of adult patients with relapsed or refractory multiple myeloma who have previously received at least 4 lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody.

Data on 10 social determinants of health (SDOH) were analyzed to determine their distribution among low-income patients hospitalized for heart failure (HF) at a safety-net hospital.

Better transparency is needed for nonemergency hospital care expenses; services and support are needed to alleviate the financial strain of caring for older adults; a reduced demand for annual COVID-19 vaccination is putting pressure on public health officials.

The rare disease can cause burning, stabbing, or shooting pain in patients.

Researchers conducted systematic mapping of relevant digital health intervention literature to determine the impact of these interventions on dermatologic care outcomes.

The presence of sex differences in immunological functioning influences hidradenitis suppurativa (HS).

Researchers suggest providers learning more about e-cigarettes and updated, effective cessation methods could help their patients overcome barriers to smoking cessation treatment.

New research suggests that measuring the inflammatory marker myeloperoxidase (MPO) may be an effective strategy for the prediction of patients' risk of mortality in a myriad of cardiac—and potentially non-cardiac—diseases.

Data from 2 studies, LIGHTHOUSE and SPOTLIGHT, have shown the benefit of flotufolastat F 18 injection as a radiohybrid PSMA-targeted PET imaging agent in prostate cancer. The agent has now been added to the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology.

BeginNGS aims to enable the prompt identification of potential genetic disease with its newborn screening program.

Findings from a retrospective analysis suggest an association between bridging therapy and poorer outcomes among patients with aggressive, relapsed/refractory B-cell non-Hodgkin lymphoma (NHL).

An overall survival (OS analysis of the phase 3 ZUMA-7 trial demonstrated longer OS in patients treated with axicabtagene ciloleucel (axi-cel) vs the standard of care for early relapsed or refractory (R/R) large B-cell lymphoma (LBCL).

Researchers found that costs were highest for those with hospital-onset clostridioides difficile infection (CDI), lower for those with community onset-health care facility association CDI, and lowest for those with community-associated CDI.

Studies showed the various treatments improved symptoms, but more trials need to be done.

New biomarker technology shows promising results for predicting the prognosis of patients with prostate cancer after radical prostatectomy.

The program, which scales an accountable care organization (ACO) model across all major payers in Vermont, reduced Medicare spending and hospitalizations while improving patient care.

Patients given LNK01001 showed significant improvement in Eczema Area and Severity Index scores over placebo.

New research found that ovarian cancer risk is reduced by salpingectomy just as much as by tubal ligation, contradicting guidelines that suggest otherwise.

The BeginNGS program added 23 new founding members to the consortium and expanded to include 31 additional genetic disorders in its second phase screening, totaling 419 treatable genetic disorders.

One in 3 hospitals report issues with chemotherapy drug shortages; the suicide rate in the United States hit an all-time high in 2022; an acid reflux medication may be linked with higher risk of dementia.